Persistent infection with oncogenic human papillomavirus (HPV) is a necessary cause of
cervical cancer. Moreover, HPV type 16 (and to a lesser degree HPV type 18) is linked with …

Persistent infection with oncogenic human papillomavirus (HPV) is a necessary causal
factor in the development of cervical cancer. Moreover, HPV, predominately type 16 and to a …

Prophylactic human papillomavirus vaccine efficacy is almost too good to be true. The
benefits of herd immunity will, however, not be gained without high vaccine coverage. Here …

Current status of human papillomavirus vaccination : Current Opinion in Oncology Current status
of human papillomavirus vaccination : Current Opinion in Oncology Log in or Register Subscribe …

Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …

Since 2006, three vaccines against infections and disease caused by human papillomavirus
(HPV) became available in Europe—in 2006 a quadrivalent HPV 6/11/16/18 vaccine, in …

Globally, human papillomavirus (HPV) infection is one of the most common sexually
transmitted infection. HPV is linked to at least five malignancies including vulvar, vaginal …

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide.
Primary prevention thorough vaccination si able to reduce the burden of HPV-related …

Human Papillomavirus (HPV) infection causes cervical cancer, a significant portion of anal,
vulvar, vaginal, and oropharyngeal cancers, genital warts, and recurrent respiratory …